BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26024798)

  • 1. Upregulation of a disintegrin and metalloprotease 8 is associated with progression and prognosis of patients with gastric cancer.
    Huang J; Bai Y; Huo L; Xiao J; Fan X; Yang Z; Chen H; Yang Z
    Transl Res; 2015 Dec; 166(6):602-13. PubMed ID: 26024798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Netrin-4 as a biomarker promotes cell proliferation and invasion in gastric cancer.
    Lv B; Song C; Wu L; Zhang Q; Hou D; Chen P; Yu S; Wang Z; Chu Y; Zhang J; Yang D; Liu J
    Oncotarget; 2015; 6(12):9794-806. PubMed ID: 25909166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and clinical implication of a disintegrin and metalloprotease 8 expression in pediatric medulloblastoma.
    Zhang R; Yuan Y; Zuo J; Liu W
    J Neurol Sci; 2012 Dec; 323(1-2):46-51. PubMed ID: 22959284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
    Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancer.
    Yang Z; Bai Y; Huo L; Chen H; Huang J; Li J; Fan X; Yang Z; Wang L; Wang J
    BMC Cancer; 2014 Aug; 14():568. PubMed ID: 25098630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.
    Li Z; Liao Q; Wu Y; Liao M; Hao Y; Zhang S; Song S; Li B; Zhang YD
    Pathol Oncol Res; 2012 Jul; 18(3):657-61. PubMed ID: 22215309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.
    Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG
    Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of a disintegrin and metalloprotease 8 in allergic rhinitis.
    Park IH; Choi SW; Choi H; Kim TH; Lee SH; Lee SH; Lee HM
    Am J Rhinol Allergy; 2011; 25(3):107-11. PubMed ID: 21679521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis.
    He S; Ding L; Cao Y; Li G; Deng J; Tu Y; Wang B
    Med Oncol; 2012 Sep; 29(3):2032-7. PubMed ID: 21983884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
    Wildeboer D; Naus S; Amy Sang QX; Bartsch JW; Pagenstecher A
    J Neuropathol Exp Neurol; 2006 May; 65(5):516-27. PubMed ID: 16772875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
    Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
    Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of GOLPH2 is associated with the progression of and poor prognosis in gastric cancer.
    Liu G; Zhang Y; He F; Li J; Wei X; Li Y; Liao X; Sun J; Yi W; Niu D
    Oncol Rep; 2014 Nov; 32(5):2077-85. PubMed ID: 25119897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of a disintegrin and metalloprotease-9 in hepatocellular carcinoma: implications for tumor progression and prognosis.
    Tao K; Qian N; Tang Y; Ti Z; Song W; Cao D; Dou K
    Jpn J Clin Oncol; 2010 Jul; 40(7):645-51. PubMed ID: 20388695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion.
    Wang L; Wu Y; Lin L; Liu P; Huang H; Liao W; Zheng D; Zuo Q; Sun L; Huang N; Shi M; Liao Y; Liao W
    Int J Cancer; 2013 Sep; 133(6):1419-30. PubMed ID: 23457029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.
    Sriraman V; Eichenlaub-Ritter U; Bartsch JW; Rittger A; Mulders SM; Richards JS
    Biol Reprod; 2008 Jun; 78(6):1038-48. PubMed ID: 18287572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
    Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
    Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis.
    Fritzsche FR; Jung M; Xu C; Rabien A; Schicktanz H; Stephan C; Dietel M; Jung K; Kristiansen G
    Virchows Arch; 2006 Dec; 449(6):628-36. PubMed ID: 17106710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway.
    Cheng TY; Wu MS; Lin JT; Lin MT; Shun CT; Huang HY; Hua KT; Kuo ML
    Cancer; 2012 Dec; 118(23):5757-67. PubMed ID: 22736399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.